The healthcare giant just took a major step that could reshape its MedTech business and boost its dividend track record.

Johnson & Johnson is set to report its Q4 results on Wednesday, facing one of the most important transitions in its modern ...

Johnson & Johnson (JNJ) is expected to announce a 21% jump in its fourth quarter earnings on January 21, before the bell.

A Baltimore jury ordered Johnson & Johnson and its subsidiaries to pay over $1.5 billion to a woman who claimed decades of exposure to asbestos in the company’s talc-based products caused her ...

By Jonathan Stempel Jan 12 (Reuters) - Johnson & Johnson convinced Delaware's highest court to throw out part of a $1 billion ...

Johnson & Johnson trades above 21x forward EPS with $24B in Q3 revenue, and a raised FY25 sales guidance outlook. Read why JNJ stock is downgraded to hold.

Q4 2025 earnings call highlights: 2026 guidance to $100B sales, EPS outlook, key drug growth and risks—read the insights now.

A Los Angeles jury awarded $40 million on Friday to two women who claimed that talcum powder made by Johnson & Johnson caused their ovarian cancer. The giant health care company said it would appeal ...

A Baltimore jury ordered Johnson & Johnson and its subsidiaries to pay over $1.5 billion to a woman who claimed decades of exposure to asbestos in the company’s talc-based products caused her ...

Hindsight is always 20/20, and nowhere is this more evident than in the stock market. But that doesn’t stop investors from trying to determine what they would have made if they had actually invested ...